No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
LEXXW LEXARIA BIOSCIENCE CORP C/WTS(TO PUR COM)
- 1.1000
- 0.00000.00%
Close Jul 23 16:00 ET
5.61MMarket Cap1.72P/E (TTM)
0.0000High0.0000Low0Volume1.1000Open1.1000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)5.10MShares2.500052wk High0.48P/B5.61MFloat Cap0.050052wk Low--Dividend TTM5.10MShs Float5.1900Historical High--Div YieldTTM0.00%Amplitude0.0500Historical Low--Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Lexaria Preparing For Strategic Growth, Expanding Its Management Team This Summer As It Prepares For The Greater Workload Of Multiple Projects And Initiatives; Appoints Nelson Cabatuan As Chief Strategic Financial Advisor, Resigning From His Current...
Lexaria Preparing For Strategic Growth
10-Q: Quarterly report
Dosing Is Complete in Lexaria's Second GLP-1 Human Pilot Study
Lexaria Receives New Patents For Antiviral Drug Delivery and for Treating Epilepsy
Dosing Continues in Lexaria's Second GLP-1 Human Pilot Study
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg